logo

ITI Pharma and Healthcare Fund - Regular Plan - Growth Option

Category: Equity: Sectoral-Pharma and Healthcare Launch Date: 08-11-2021
AUM:

₹ 229.93 Cr

Expense Ratio

2.35%

Benchmark

NIFTY Healthcare TRI.

ISIN

INF00XX01BL5

Minimum Investment

5000.0

Minimum Topup

1000.0

Minimum SIP Amount

500

Fund Manager

Mr. Dhimant Shah, Mr. Rohan Korde, Mr. Rajesh Bhatia

Fund Performance 1Y (%) 3Y (%) 5Y (%)
ITI Pharma and Healthcare Fund - Regular Plan - Growth Option 4.25 21.07 -
NIFTY Healthcare TRI 6.94 22.63 17.46
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%

Overview

NAV
16.3374
Last change
-0.12 (-0.7296%)
Fund Size (AUM)
₹ 229.93 Cr
Performance
13.92% (Inception)

Asset Allocation

Equity

Debt

Others

Nav Movement

Investment Objective

The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare. However, there can be no assurance that the investment objective of the scheme would be achieved.

Fund Manager
Mr. Dhimant Shah, Mr. Rohan Korde, Mr. Rajesh Bhatia
Riskometer
Very High

Top 10 Holdings

Company Holdings (%)
SUN PHARMACEUTICAL INDUSTRIES LTD. EQ NEW F.V. RE.1/- 10.93
DIVIS LABORATORIES LIMITED EQ NEW RS. 2/- 8.68
MAX HEALTHCARE INSTITUTE LIMITED EQ 6.12
APOLLO HOSPITALS ENTERPRISE LIMITED EQ NEW F.V. RS.5/- 5.66
SUVEN PHARMACEUTICALS LIMITED EQ 4.66
TORRENT PHARMACEUTICALS LIMITED EQ NEW FV RS.5/- 4.58
AUROBINDO PHARMA LIMITED EQ NEW F.V. RE.1/- 3.66
FORTIS HEALTHCARE LIMITED. EQ 3.51
LUPIN LIMITED EQ NEW F.V. RS.2/- 3.46
ASTER DM HEALTHCARE LIMITED EQ 3.19

Sector Allocation

Sector Holdings (%)
Healthcare 90.27
Chemicals 5.29
Information Technology 1.27
Capital Goods 0.84
Financial Services 0.73
Diversified 0.31